Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6124478 | Osteoarthritis and Cartilage | 2016 | 26 Pages |
Abstract
LOXL3, a downstream of leptin, stimulated the apoptosis, but inhibited the autophagy of chondrocytes. LOXL3 is a potential therapy target for osteoarthritis.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Z.M. Huang, S.H. Du, L.G. Huang, J.H. Li, L. Xiao, P. Tong,